Ectopic pregnancy is a common cause of pregnancy-related morbidity and mortality. It occurs when a fertilized egg implants outside the uterus, usually in the fallopian tube. It is a dangerous condition for the mother, as the fertilized egg can rupture the fallopian tube and cause internal bleeding. Accurate diagnosis of ectopic pregnancy is essential for proper management and treatment. One of the most commonly used tests for the diagnosis of ectopic pregnancy is the measurement of human chorionic gonadotropin (hCG) levels.
Human chorionic gonadotropin (hCG) is a hormone produced by the placenta during pregnancy. It is produced by the cells that will eventually become the placenta and is responsible for maintaining the pregnancy. It is detectable in the blood and urine of pregnant women.
The main role of hCG in the diagnosis of ectopic pregnancy is to detect the presence of a viable pregnancy. If hCG levels are found to be low or not increasing, it may indicate that the pregnancy is not viable or is ectopic.
hCG levels are typically measured with a blood test. The test measures the amount of hCG in the blood and is usually done in the first trimester of pregnancy. A urine test may also be used to measure hCG levels.
Normal hCG levels vary depending on the stage of pregnancy. In the first trimester, normal hCG levels typically range from 10 to 100 mIU/mL. In the second trimester, normal hCG levels range from 1,000 to 10,000 mIU/mL. In the third trimester, normal hCG levels range from 10,000 to 50,000 mIU/mL.
An ectopic pregnancy is typically diagnosed with a combination of tests. These tests include a pelvic exam, an ultrasound, and a blood test to measure hCG levels. If the hCG levels are found to be low or not increasing, it may indicate that the pregnancy is not viable or is ectopic.
Treatment for an ectopic pregnancy depends on the location and size of the pregnancy. In some cases, the pregnancy may be able to be managed medically with medications. In other cases, surgery may be necessary to remove the pregnancy.
Accurate diagnosis of ectopic pregnancy is essential for proper management and treatment. One of the most commonly used tests for the diagnosis of ectopic pregnancy is the measurement of human chorionic gonadotropin (hCG) levels. hCG levels are typically measured with a blood test and normal hCG levels vary depending on the stage of pregnancy. An ectopic pregnancy is typically diagnosed with a combination of tests, including a pelvic exam, an ultrasound, and a blood test to measure hCG levels. Treatment for an ectopic pregnancy depends on the location and size of the pregnancy and can range from medication to surgery.
1.
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy
2.
New drug combination shows good results in patients with HPV-negative head and neck cancer
3.
high response rate when using a bispecific antibody to treat R/R multiple myeloma.
4.
Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC
5.
Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant
1.
Environmental Carcinogen Exposure Screening: Advances, Clinical Implications, and Guideline-Based Approaches
2.
A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies
3.
Progressive Insights in Hematology in the Digital Era
4.
Analyzing the Mechanisms and Efficacy of Carboplatin, Abraxane, and Albumin-Bound Formulations
5.
The importance of understanding normal serum osmolality
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation